Swirsky Douglas J
Insider CIK 1375884 · PTX Director · RNN President and CFO, Director · CLRB Director · MXCT Chief Financial Officer · PYMX.OB Director · NRBO Director · FCSC Director · GNVC Senior Vice President & CFO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CLRB Cellectar Biosciences, Inc | A Award deriv | 2026-07-07 | 2026-07-08 | 37,500 | — | $0 | 37,500 | SEC↗ |
| MXCT MAXCYTE, INC. | S Sale | 2026-03-17 | 2026-03-19 | 10,142 | $0.82 | $8.3K | 151,669 | SEC↗ |
| MXCT MAXCYTE, INC. | P Buy | 2025-08-13 | 2025-08-13 | 50,000 | $1.29 | $64.5K | 161,811 | SEC↗ |
| MXCT MAXCYTE, INC. | S Sale | 2025-03-18 | 2025-03-20 | 6,939 | $3.18 | $22.1K | 111,811 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2025-03-14 | 2025-03-18 | 150,000 | — | $0 | 150,000 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award | 2025-03-14 | 2025-03-18 | 37,500 | — | $0 | 118,750 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | A Award deriv | 2025-02-14 | 2025-02-18 | 90,000 | — | $0 | 90,000 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | A Award deriv | 2024-06-14 | 2024-06-18 | 90,000 | — | $0 | 90,000 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2024-03-15 | 2024-03-19 | 225,000 | — | $0 | 225,000 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award | 2024-03-15 | 2024-03-19 | 81,250 | — | $0 | 81,250 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | A Award deriv | 2023-06-28 | 2023-06-28 | 37,500 | — | $0 | 71,925 | SEC↗ |
| MXCT MAXCYTE, INC. | A Award deriv | 2023-03-27 | 2023-03-28 | 350,000 | — | $0 | 350,000 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | A Award deriv | 2022-06-24 | 2022-08-01 | 11,700 | — | $0 | 11,700 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | P Buy | 2021-09-14 | 2021-09-14 | 25,000 | $1.04 | $26.0K | 25,000 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | A Award deriv | 2021-06-30 | 2021-07-02 | 117,000 | — | $0 | 117,000 | SEC↗ |
| NRBO NeuroBo Pharmaceuticals, I | A Award deriv | 2020-09-01 | 2020-09-03 | 60,000 | — | $0 | 60,000 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | A Award deriv | 2020-06-24 | 2020-06-25 | 80,000 | — | $0 | 80,000 | SEC↗ |
| FCSC Fibrocell Science, Inc. | D To issuer deriv | 2019-12-13 | 2019-12-13 | 2,400 | — | $0 | 0 | SEC↗ |
| FCSC Fibrocell Science, Inc. | D To issuer deriv | 2019-12-13 | 2019-12-13 | 534 | — | $0 | 0 | SEC↗ |
| FCSC Fibrocell Science, Inc. | D To issuer deriv | 2019-12-13 | 2019-12-13 | 6,000 | — | $0 | 0 | SEC↗ |
| FCSC Fibrocell Science, Inc. | D To issuer deriv | 2019-12-13 | 2019-12-13 | 6,000 | — | $0 | 0 | SEC↗ |
| FCSC Fibrocell Science, Inc. | D To issuer deriv | 2019-12-13 | 2019-12-13 | 2,400 | — | $0 | 0 | SEC↗ |
| FCSC Fibrocell Science, Inc. | D To issuer deriv | 2019-12-13 | 2019-12-13 | 12,000 | — | $0 | 0 | SEC↗ |
| FCSC Fibrocell Science, Inc. | D To issuer deriv | 2019-12-13 | 2019-12-13 | 1,200 | — | $0 | 0 | SEC↗ |
| FCSC Fibrocell Science, Inc. | D To issuer deriv | 2019-12-13 | 2019-12-13 | 1,600 | — | $0 | 0 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | A Award deriv | 2019-06-13 | 2019-06-14 | 9,750 | — | $0 | 9,750 | SEC↗ |
| FCSC Fibrocell Science, Inc. | A Award deriv | 2019-06-12 | 2019-06-14 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | P Buy | 2019-01-29 | 2019-01-30 | 50,000 | $0.63 | $31.5K | 50,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2018-11-14 | 2018-11-16 | 500,000 | — | $0 | 500,000 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | A Award deriv | 2018-10-12 | 2018-10-15 | 19,500 | — | $0 | 19,500 | SEC↗ |
| FCSC Fibrocell Science, Inc. | A Award deriv | 2018-06-19 | 2018-06-21 | 6,000 | — | $0 | 6,000 | SEC↗ |
| PTX PERNIX THERAPEUTICS HOLDIN | A Award deriv | 2018-05-22 | 2018-05-23 | 25,000 | — | $0 | 25,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2018-01-02 | 2018-01-04 | 250,000 | — | $0 | 250,000 | SEC↗ |
| PTX PERNIX THERAPEUTICS HOLDIN | A Award deriv | 2017-11-15 | 2017-11-17 | 50,000 | — | $0 | 50,000 | SEC↗ |
| FCSC Fibrocell Science, Inc. | A Award deriv | 2017-06-22 | 2017-06-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| GNVC GENVEC INC | M Exercise deriv | 2017-06-16 | 2017-06-20 | 25,000 | $5.60 | $140.0K | 0 | SEC↗ |
| GNVC GENVEC INC | M Exercise | 2017-06-16 | 2017-06-20 | 25,000 | $5.60 | $140.0K | 50,250 | SEC↗ |
| GNVC GENVEC INC | D To issuer | 2017-06-16 | 2017-06-20 | 29,320 | — | $0 | 0 | SEC↗ |
| CLRB Cellectar Biosciences, Inc | A Award deriv | 2017-05-31 | 2017-06-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2016-09-16 | 2016-09-16 | 10,000 | $0.50 | $5.0K | 252,500 | SEC↗ |
| FCSC Fibrocell Science, Inc. | A Award deriv | 2016-06-22 | 2016-06-23 | 36,000 | — | $0 | 36,000 | SEC↗ |
| GNVC GENVEC INC | F Tax w/h | 2016-06-16 | 2017-06-20 | 20,930 | $7.19 | $150.5K | 29,320 | SEC↗ |
| GNVC GENVEC INC | A Award deriv | 2016-01-29 | 2016-02-01 | 250,000 | — | $0 | 250,000 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2015-12-14 | 2015-12-15 | 5,000 | $2.00 | $10.0K | 242,500 | SEC↗ |
| FCSC Fibrocell Science, Inc. | A Award deriv | 2015-06-24 | 2015-06-25 | 36,000 | — | $0 | 36,000 | SEC↗ |
| GNVC GENVEC INC | A Award deriv | 2015-01-16 | 2015-01-16 | 200,000 | — | $0 | 200,000 | SEC↗ |
| GNVC GENVEC INC | P Buy | 2014-12-15 | 2015-08-07 | 5,500 | $1.90 | $10.4K | 237,500 | SEC↗ |
| GNVC GENVEC INC | A Award | 2014-12-15 | 2014-12-15 | 5,500 | $1.90 | $10.4K | 237,500 | SEC↗ |
| FCSC Fibrocell Science, Inc. | A Award deriv | 2014-06-20 | 2014-06-24 | 18,000 | — | $0 | 18,000 | SEC↗ |
| GNVC GENVEC INC | A Award deriv | 2014-01-23 | 2014-01-24 | 75,000 | — | $0 | 75,000 | SEC↗ |
| GNVC GENVEC INC | A Award | 2013-09-03 | 2013-09-05 | 200,000 | — | $0 | 232,000 | SEC↗ |
| FCSC Fibrocell Science, Inc. | A Award deriv | 2013-07-19 | 2013-07-23 | 24,000 | — | $0 | 32,000 | SEC↗ |
| FCSC Fibrocell Science, Inc. | A Award deriv | 2013-03-04 | 2013-03-05 | 200,000 | — | $0 | 200,000 | SEC↗ |
| GNVC GENVEC INC | A Award deriv | 2013-01-22 | 2013-01-24 | 125,000 | — | $0 | 125,000 | SEC↗ |
| PYMX.OB POLYMEDIX, INC | A Award deriv | 2012-03-26 | 2012-03-28 | 37,000 | — | $0 | 37,000 | SEC↗ |
| GNVC GENVEC INC | A Award deriv | 2012-01-18 | 2012-01-20 | 60,000 | — | $0 | 60,000 | SEC↗ |